Shane Schaffer
Algemeen Directeur bij CINGULATE INC.
Vermogen: 35 672 $ op 30-04-2024
Profiel
Shane J.
Schaffer is the founder of Cingulate Works, Inc. and Cingulate, Inc. both founded in 2013, where he holds the title of Chairman & Chief Executive Officer.
Dr. Schaffer is also the founder of Cingulate Therapeutics LLC.
He held former positions as Managing Director at Sabre Scientific Solutions from 2009 to 2012, Marketing Manager at Novartis International AG from 2001 to 2003, Clinical Research Associate at Hoechst Marion Roussel, Inc. from 1997 to 1999, and Senior Manager-Marketing at Sanofi SA from 2004 to 2007.
Dr. Schaffer earned a doctorate degree from KU School of Pharmacy.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CINGULATE, INC.
1.07% | 15-04-2024 | 42 467 ( 1.07% ) | 35 672 $ | 30-04-2024 |
Actieve functies van Shane Schaffer
| Bedrijven | Functie | Begin |
|---|---|---|
| CINGULATE INC. | Algemeen Directeur | 01-01-2013 |
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Algemeen Directeur | 01-01-2013 |
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Algemeen Directeur | 01-01-2013 |
Eerdere bekende functies van Shane Schaffer
| Bedrijven | Functie | Einde |
|---|---|---|
| Sabre Scientific Solutions | Corporate Officer/Principal | 01-12-2012 |
| Sanofi SA | Verkoop & Marketing | 01-12-2007 |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Verkoop & Marketing | 01-10-2003 |
| Hoechst Marion Roussel, Inc. | Corporate Officer/Principal | 01-07-1999 |
Opleiding van Shane Schaffer
| KU School of Pharmacy | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CINGULATE INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Health Technology |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
| Hoechst Marion Roussel, Inc. | |
| Sanofi SA | Health Technology |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
| Sabre Scientific Solutions |
